Profil
Ioana C.
Hone is currently working as an Investor Relations Contact at Lineage Cell Therapeutics, Inc. Previously, she worked as a Director-Investor Relations at LifeVantage Corp., Mast Therapeutics, Inc., and as an Investor Relations Contact at Savara, Inc.
Postes actifs de Ioana C. Hone
Sociétés | Poste | Début |
---|---|---|
LINEAGE CELL THERAPEUTICS, INC. | Investor Relations Contact | - |
Anciens postes connus de Ioana C. Hone
Sociétés | Poste | Fin |
---|---|---|
LIFEVANTAGE CORPORATION | Public Communications Contact | - |
SAVARA INC. | Investor Relations Contact | - |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
LIFEVANTAGE CORPORATION | Health Technology |
SAVARA INC. | Health Technology |
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |